Artelo Historical Income Statement
| ARTL Stock | USD 0.97 0.00 0.000003% |
Historical analysis of Artelo Biosciences income statement accounts such as Selling General Administrative of 2.3 M, Total Revenue of 0.0 or Gross Profit of 0.0 can show how well Artelo Biosciences performed in making a profits. Evaluating Artelo Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Artelo Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Artelo Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Artelo Biosciences is a good buy for the upcoming year.
Artelo Biosciences Net Income |
|
Artelo |
About Artelo Income Statement Analysis
Artelo Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Artelo Biosciences shareholders. The income statement also shows Artelo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Artelo Biosciences Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Artelo Biosciences. It is also known as Artelo Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Artelo Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Artelo Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.At this time, Artelo Biosciences' Depreciation And Amortization is quite stable compared to the past year. Reconciled Depreciation is expected to rise to 440.83 this year, although the value of Operating Income is projected to rise to (9.4 M).
Artelo Biosciences income statement Correlations
Click cells to compare fundamentals
Artelo Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Artelo Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Selling General Administrative | 2.1M | 2.8M | 4.6M | 6.0M | 4.2M | 2.3M | |
| Other Operating Expenses | 3.2M | 4.7M | 7.4M | 10.3M | 11.8M | 12.4M | |
| Operating Income | (3.2M) | (4.7M) | (7.4M) | (10.3M) | (9.9M) | (9.4M) | |
| Net Income From Continuing Ops | (2.2M) | (4.7M) | (7.4M) | (10.3M) | (9.3M) | (8.8M) | |
| Ebit | (4.2M) | (4.7M) | (7.4M) | (10.3M) | (9.3M) | (8.8M) | |
| Ebitda | (4.2M) | (4.7M) | (7.4M) | (10.3M) | (9.3M) | (8.8M) | |
| Total Operating Expenses | 3.2M | 4.7M | 7.4M | 10.3M | 9.9M | 10.4M | |
| Income Before Tax | (2.2M) | (4.7M) | (7.4M) | (10.1M) | (9.3M) | (8.8M) | |
| Total Other Income Expense Net | 1.0M | 30.9K | 2K | 204K | 641K | 673.1K | |
| Net Income Applicable To Common Shares | (2.3M) | (2.2M) | (4.7M) | (7.4M) | (6.7M) | (6.4M) | |
| Net Income | (2.2M) | (4.7M) | (7.4M) | (9.9M) | (9.3M) | (8.8M) | |
| Income Tax Expense | (2.0M) | (60.4K) | (4K) | (209K) | (188.1K) | (197.5K) | |
| Research Development | 1.1M | 1.9M | 2.8M | 4.3M | 5.7M | 6.0M | |
| Depreciation And Amortization | 510.0 | 500.0 | (2K) | 2K | 2.3K | 2.4K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.87) | Return On Assets (0.54) | Return On Equity (0.89) |
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.